Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q57129922> ?p ?o ?g. }

Showing items 1 to 100 of ±109 with 100 items per page.

Q57129922 description "article scientifique publié en 2013" @default.
Q57129922 description "im Dezember 2013 veröffentlicher wissenschaftlicher Artikel" @default.
Q57129922 description "wetenschappelijk artikel" @default.
Q57129922 description "наукова стаття, опублікована в грудні 2013" @default.
Q57129922 name "Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a r" @default.
Q57129922 name "Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a r" @default.
Q57129922 type Item @default.
Q57129922 label "Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a r" @default.
Q57129922 label "Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a r" @default.
Q57129922 prefLabel "Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a r" @default.
Q57129922 prefLabel "Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a r" @default.
Q57129922 P1433 Q57129922-418377E4-F8C0-4486-806A-97EB8DCBA1BF @default.
Q57129922 P1476 Q57129922-C101C01C-A557-4C01-9848-3439A0A65D5E @default.
Q57129922 P2093 Q57129922-09578952-B587-4B32-BAFA-95F73F798420 @default.
Q57129922 P2093 Q57129922-112A5EA4-4E9C-4778-8EA0-83068BBBF753 @default.
Q57129922 P2093 Q57129922-1F7DB517-F54C-471C-857B-8C89C400EB76 @default.
Q57129922 P2093 Q57129922-70901D9D-5054-4586-BAA9-ADFAAE686EB4 @default.
Q57129922 P2093 Q57129922-A70E9C74-DCEA-4A71-BDEF-29ACF4B45417 @default.
Q57129922 P2093 Q57129922-FC4C2403-EABC-42D2-AD6E-D0903F2D4846 @default.
Q57129922 P2860 Q57129922-038583C1-6FB6-4F83-9573-BAA1A6ED962D @default.
Q57129922 P2860 Q57129922-081CF008-F85C-41D6-B349-55AFB2EBC9B2 @default.
Q57129922 P2860 Q57129922-0A141E07-4165-4CB5-873D-C5A15EB5AAFE @default.
Q57129922 P2860 Q57129922-26BCDEC5-7EE7-466F-8599-33E1376B77EA @default.
Q57129922 P2860 Q57129922-57D73734-6852-4603-A70D-9B01709C4CE8 @default.
Q57129922 P2860 Q57129922-5E155A29-9BD6-44A1-A355-163ABEF538C7 @default.
Q57129922 P2860 Q57129922-5E4D3600-52DD-4085-927F-235133D5E673 @default.
Q57129922 P2860 Q57129922-65BA9D2A-FA05-4CCF-A773-2F144FAF10BE @default.
Q57129922 P2860 Q57129922-7E6A2011-5CB3-461A-9927-0FF8C052FEF3 @default.
Q57129922 P2860 Q57129922-83E429A3-B010-44A9-8953-561C376028DC @default.
Q57129922 P2860 Q57129922-8EBDA51A-922E-4F0B-A64D-0CAA21EE4326 @default.
Q57129922 P2860 Q57129922-98DB2E88-C852-4615-8AD9-A4DD5DC7EDEA @default.
Q57129922 P2860 Q57129922-A1313096-BBA1-4C41-AA0D-BBFF47CB4204 @default.
Q57129922 P2860 Q57129922-A91425FF-387B-4176-8C65-63A33BC191F6 @default.
Q57129922 P2860 Q57129922-AC5A3C3A-B1F5-4E47-A01A-1A155E0515E4 @default.
Q57129922 P2860 Q57129922-BE195586-BCB6-492B-A502-CE480D2A1545 @default.
Q57129922 P2860 Q57129922-C373CFEB-F984-4625-993C-EC6AB27F49BF @default.
Q57129922 P2860 Q57129922-C721A354-2CB8-4093-867A-BD2DF55EF3B2 @default.
Q57129922 P2860 Q57129922-CA4C012E-7BD1-408E-AB9A-8179A3AB7D36 @default.
Q57129922 P2860 Q57129922-F1064A8F-6692-4160-A321-1196CBA90F0A @default.
Q57129922 P2860 Q57129922-FCA1A40A-2A20-4503-A596-C9B76393CFD4 @default.
Q57129922 P304 Q57129922-DBDA8B02-B049-424D-898C-7EB61C65E088 @default.
Q57129922 P31 Q57129922-B62CF5EA-BD0E-400A-9D0F-C61B9AEA8CA1 @default.
Q57129922 P356 Q57129922-1C5B89CF-8140-41B3-B0CF-069B4F0C5602 @default.
Q57129922 P407 Q57129922-8BDCF233-A4F4-4AA1-85BD-733F2B1FE640 @default.
Q57129922 P433 Q57129922-93CE5A06-01BC-4361-BA0E-EBB5DFDA7058 @default.
Q57129922 P478 Q57129922-F167221E-7800-4740-B257-D40415CFD921 @default.
Q57129922 P50 Q57129922-0A1D1793-FBA8-406F-8AD7-238B98573CE2 @default.
Q57129922 P50 Q57129922-6C261920-1031-4B46-BADD-3B92DB687179 @default.
Q57129922 P50 Q57129922-A77C295A-53B3-4056-9EB8-3A4A26DFB8A3 @default.
Q57129922 P50 Q57129922-C957FF48-41EA-485F-BAFE-EB440DEF920E @default.
Q57129922 P50 Q57129922-F045CF4D-5FCE-41F2-91B0-6CAD2F283DBE @default.
Q57129922 P577 Q57129922-5301B810-1746-4E56-BF29-BB272C9EB072 @default.
Q57129922 P698 Q57129922-D9EA7105-DDF4-4919-A0A7-F75271981D55 @default.
Q57129922 P921 Q57129922-1B12CD5E-D011-4939-82CC-6E43525A56B1 @default.
Q57129922 P921 Q57129922-3295E692-1403-4089-BC07-8853BB8D9FB8 @default.
Q57129922 P921 Q57129922-3B6C9DE4-EE0B-4B58-ACD2-F61A3374CDFA @default.
Q57129922 P921 Q57129922-8CF4BC17-92C4-44FA-B1C8-BB81DE51E0FE @default.
Q57129922 P921 Q57129922-A92ADBAC-23A7-45BD-AAC4-2EA210CC22C9 @default.
Q57129922 P932 Q57129922-811107A4-4481-4A5B-9B1F-B0F9B076E7CF @default.
Q57129922 P356 S1470-2045(13)70502-3 @default.
Q57129922 P698 24239210 @default.
Q57129922 P1433 Q13747613 @default.
Q57129922 P1476 "Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a r" @default.
Q57129922 P2093 "A Marilyn Leitch" @default.
Q57129922 P2093 "Gary Unzeitig" @default.
Q57129922 P2093 "Linda M McCall" @default.
Q57129922 P2093 "Matthew J Ellis" @default.
Q57129922 P2093 "Melanie Royce" @default.
Q57129922 P2093 "Michael S Ewer" @default.
Q57129922 P2860 Q27824766 @default.
Q57129922 P2860 Q27824847 @default.
Q57129922 P2860 Q27851705 @default.
Q57129922 P2860 Q27851763 @default.
Q57129922 P2860 Q28254919 @default.
Q57129922 P2860 Q29616112 @default.
Q57129922 P2860 Q31089499 @default.
Q57129922 P2860 Q36973572 @default.
Q57129922 P2860 Q37079625 @default.
Q57129922 P2860 Q37118500 @default.
Q57129922 P2860 Q38474138 @default.
Q57129922 P2860 Q40442632 @default.
Q57129922 P2860 Q42637089 @default.
Q57129922 P2860 Q43121689 @default.
Q57129922 P2860 Q43180234 @default.
Q57129922 P2860 Q45287928 @default.
Q57129922 P2860 Q46764831 @default.
Q57129922 P2860 Q54516956 @default.
Q57129922 P2860 Q57579927 @default.
Q57129922 P2860 Q73494751 @default.
Q57129922 P2860 Q84247183 @default.
Q57129922 P304 "1317-25" @default.
Q57129922 P31 Q13442814 @default.
Q57129922 P356 "10.1016/S1470-2045(13)70502-3" @default.
Q57129922 P407 Q1860 @default.
Q57129922 P433 "13" @default.
Q57129922 P478 "14" @default.
Q57129922 P50 Q114440916 @default.
Q57129922 P50 Q67191264 @default.
Q57129922 P50 Q90520703 @default.
Q57129922 P50 Q92381506 @default.